Markers of Neuroendocrine Differentiation in Prostate Cancer
Author Information
Author(s): Ather M Hammad, Abbas Farhat, Faruqui Nuzhat, Israr Mohammad, Pervez Shahid
Primary Institution: Aga Khan University
Hypothesis
The study investigates the correlation of immunohistochemical markers of neuroendocrine differentiation with disease progression in prostate cancer.
Conclusion
CgA is a better predictor of disease at presentation compared to other markers, and both CgA and NSE show increasing expression with worsening histological grade.
Supporting Evidence
- CgA was detected in 33 cases, Syn in 8 cases, and NSE in 44 cases.
- Expression of CgA was seen in 7% of organ confined disease, 37% in locally invasive, and 35% in metastatic patients.
- Both CgA and NSE had increasing expression with worsening Gleason grade.
Takeaway
This study looked at how certain markers in prostate cancer can help doctors understand how serious the disease is. They found that one marker, CgA, is especially helpful.
Methodology
The study evaluated malignant prostatic specimens from 84 patients using immunohistochemical staining for neuroendocrine markers.
Limitations
The study had a small sample size and was retrospective in nature.
Participant Demographics
Patients were aged between 52 and 93 years, with a mean age of 70 ± 9.2 years.
Statistical Information
P-Value
p 0.024 for CgA, p 0.006 for NSE
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website